fda warning bpc-157 2023 2024 The FDA's Pharmacy Compounding Advisory Committee is scheduled to meet Thursday and Friday to review some of the controversial, popular peptide injections and discuss whether compounding pharmacies should be able to dispense The experts will take votes

The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The hype around a new class of injectable drugs is in overdrive, but they have yet to be properly tested. Read the full story from Kishor Napier Raman at the link in bio., Photo: Oscar Colman

SKU: 97053837509 · From vanierexcavation.com